
A hepatitis B vaccine has been ruled out in the deaths of nine children in China, a health official said. Yu Jingjin, director of the National Health and Family Planning Commission's disease control bureau, said investigators were still working on eight other fatal cases, though preliminary work had found no link to the BioKangtai vaccinations in those instances either, the state-run Xinhua News Agency reported Friday. All 17 deaths occurred Dec. 13-31, the news agency said. Li Guoqing of the China Food and Drug Administration said no issues had been uncovered in the production of the vaccine. However, China's three largest manufacturers of hepatitis B vaccine suspended production after failing to meet an end-of-the-year deadline for new certification standards, the agency announced late Thursday. BioKangtai, Tiantan Biological Products and Dalian Hissen Bio-Pharm, which account for 80 percent of the country's hepatitis B production, will have to meet the new standards before resuming production, Xinhua said. Two other producers also missed the certification deadline, leaving just two manufacturers in operation. The administration said vaccines produced before the deadline can still be sold and Li said there is an adequate supply to meet demand.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor